Explore
Validate
Learn
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA002940 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA002940, RRID:AB_1859547
- Product name
- Anti-AHNAK2
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human AHNAK2, Gene description: AHNAK nucleoprotein 2, Alternative Gene Names: C14orf78, Validated applications: ICC, IHC, Uniprot ID: Q8IVF2, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset
AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas
Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP)
Xu Y, Nipper M, Dominguez A, Ye Z, Akanuma N, Lopez K, Deng J, Arenas D, Sanchez A, Sharkey F, Court C, Singhi A, Wang H, Fernandez-Zapico M, Sun L, Zheng S, Chen Y, Liu J, Wang P
Nature Communications 2024;15(1)
Nature Communications 2024;15(1)
AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas
Xu M, Cheng A, Yu L, Wei W, Li J, Cai C
Acta Biochimica et Biophysica Sinica 2022;54(11):1708-1719
Acta Biochimica et Biophysica Sinica 2022;54(11):1708-1719
Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma
Xie Z, Lun Y, Li X, He Y, Wu S, Wang S, Sun J, He Y, Zhang J
Aging 2020;12(18):18163-18180
Aging 2020;12(18):18163-18180
Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
Klett H, Fuellgraf H, Levit-Zerdoun E, Hussung S, Kowar S, Küsters S, Bronsert P, Werner M, Wittel U, Fritsch R, Busch H, Boerries M
Frontiers in Genetics 2018;9
Frontiers in Genetics 2018;9
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
Wang M, Li X, Zhang J, Yang Q, Chen W, Jin W, Huang Y, Yang R, Gao W
Theranostics 2017;7(5):1100-1113
Theranostics 2017;7(5):1100-1113
Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP)
Fagerberg L, Oksvold P, Skogs M, Älgenäs C, Lundberg E, Pontén F, Sivertsson Å, Odeberg J, Klevebring D, Kampf C, Asplund A, Sjöstedt E, Al-Khalili Szigyarto C, Edqvist P, Olsson I, Rydberg U, Hudson P, Ottosson Takanen J, Berling H, Björling L, Tegel H, Rockberg J, Nilsson P, Navani S, Jirström K, Mulder J, Schwenk J, Zwahlen M, Hober S, Forsberg M, von Feilitzen K, Uhlén M
Journal of Proteome Research 2012;12(6):2439-2448
Journal of Proteome Research 2012;12(6):2439-2448
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human skin and skeletal muscle tissues using HPA002940 antibody. Corresponding AHNAK2 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
